Omega Healthcare Investors (OHI) Stock Price, News & Analysis

Company Overview

Omega Healthcare Investors, Inc. engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings. The company was founded on March 31, 1992 and is headquartered in Hunt Valley, MD.

Key Stats

• Today's Range: $39.50 to $40.16
• 50-Day Range: $36.10 to $40.03
• 52-Week Range: $35.04 to $44.42
• Volume: 2.08 million shs
• Average Volume: 2.25 million shs
• Market Capitalization: $11.58 billion
• P/E Ratio: 24.71
• Dividend Yield: 6.69%
• Price Target: $42.25
• Consensus Rating: Hold

Omega Healthcare Investors Stock Analysis - MarketRank™

Omega Healthcare Investors scored higher than 79% of companies evaluated by MarketBeat, and ranked 675th out of 1,824 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Omega Healthcare Investors has received a consensus rating of Hold. The company's average rating score is 2.44, and is based on 4 buy ratings, 5 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Omega Healthcare Investors has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 3.85%

Earnings Growth

Earnings for Omega Healthcare Investors are expected to grow by 3.85% in the coming year, from $2.86 to $2.97 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Omega Healthcare Investors is 24.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.84.

Price to Earnings Ratio vs. Sector

The P/E ratio of Omega Healthcare Investors is 24.71, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.89.

Price to Earnings Growth Ratio

Omega Healthcare Investors has a PEG Ratio of 2.75. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Omega Healthcare Investors has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.34% of the outstanding shares of Omega Healthcare Investors have been sold short.

Short Interest Ratio / Days to Cover

Omega Healthcare Investors has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Omega Healthcare Investors has recently decreased by 12.16%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Omega Healthcare Investors is a leading dividend payer. It pays a dividend yield of 6.74%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Omega Healthcare Investors does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Omega Healthcare Investors is 165.43%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, Omega Healthcare Investors will have a dividend payout ratio of 90.24% in the coming year. This indicates that Omega Healthcare Investors may not be able to sustain their current dividend.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -1.52

Percentage of Shares Shorted

3.34% of the outstanding shares of Omega Healthcare Investors have been sold short.

Short Interest Ratio / Days to Cover

Omega Healthcare Investors has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Omega Healthcare Investors has recently decreased by 12.16%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.99

News Sentiment

Omega Healthcare Investors has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 20 news articles for Omega Healthcare Investors this week, compared to 9 articles on an average week.

Search Interest

Only 14 people have searched for OHI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

11 people have added Omega Healthcare Investors to their MarketBeat watchlist in the last 30 days. This is an increase of 267% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Omega Healthcare Investors insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.50% of the stock of Omega Healthcare Investors is held by insiders.

Percentage Held by Institutions

65.25% of the stock of Omega Healthcare Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OHI Stock Analysis - Frequently Asked Questions

How have OHI shares performed this year?

Omega Healthcare Investors' stock was trading at $37.85 at the start of the year. Since then, OHI stock has increased by 5.8% and is now trading at $40.03.

How were Omega Healthcare Investors' earnings last quarter?

Omega Healthcare Investors, Inc. (NYSE:OHI) issued its earnings results on Thursday, July, 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The business's quarterly revenue was up 11.8% on a year-over-year basis.
Read the conference call transcript.

Who are Omega Healthcare Investors' major shareholders?

Top institutional investors of Omega Healthcare Investors include Bank of New York Mellon Corp (1.22%), Sumitomo Mitsui Trust Group Inc. (0.61%), Assetmark Inc. (0.46%) and Aberdeen Group plc (0.40%). Insiders that own company stock include Robert O Stephenson and Daniel J Booth.
View institutional ownership trends.

How do I buy shares of Omega Healthcare Investors?

Shares of OHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Omega Healthcare Investors own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Omega Healthcare Investors investors own include Chevron (CVX), Bristol Myers Squibb (BMY), AbbVie (ABBV), AT&T (T), Enterprise Products Partners (EPD), Comcast (CMCSA) and Charles Schwab (SCHW).

Company Calendar

• Record date for 5/15 Dividend: 5/05/2025
• Ex-Dividend for 5/15 Dividend: 5/05/2025
• Dividend Payable: 5/15/2025
• Last Earnings: 7/31/2025
• Record date for 8/15 Dividend: 8/04/2025
• Ex-Dividend for 8/15 Dividend: 8/04/2025
• Today: 8/05/2025
• Dividend Payable: 8/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Specialized REITs
• Current Symbol: NYSE:OHI
• CIK: 888491
• Web: www.omegahealthcare.com
• Phone: (410) 427-1700
• Fax: 410-427-8800
• Employees: 50
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Omega Healthcare Investors: $42.25
• High Price Target: $49.00
• Low Price Target: $37.00
• Potential Upside/Downside: +5.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.44
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.62
• Trailing P/E Ratio: 24.71
• Forward P/E Ratio: 14.00
• P/E Growth: 2.76
• Net Income: $406.33 million
• Net Margins: 42.23%
• Pretax Margin: 44.12%
• Return on Equity: 9.78%
• Return on Assets: 4.74%

Debt

• Debt-to-Equity Ratio: 0.96
• Current Ratio: 7.10
• Quick Ratio: 6.58

Sales & Book Value

• Annual Sales: $1.11 billion
• Price / Sales: 10.39
• Cash Flow: $2.68 per share
• Price / Cash Flow: 14.95
• Book Value: $17.52 per share
• Price / Book: 2.28

Miscellaneous

• Outstanding Shares: 289,395,000
• Free Float: 285,054,000
• Market Cap: $11.58 billion
• Optionable: Optionable
• Beta: 0.66